Skip to content
Tuesday, May 17, 2022

News

latest news

  • Business
    • Legal
    • Deals
    • Finance
    • Autos
  • World
    • U.S.
    • Special Reports
    • Mexico
    • Brasil
    • Africa
    • Russia
    • Euro Zone
    • Middle East
    • China
    • Japan
    • India
  • Politics
  • Tech
    • Science
    • Media
    • Environment
  • Commentary
  • Breaking News
  • Money
  • Life
    • Health
    • Sports
    • Arts
    • Entertainment
Health Life

U.S. FDA approves Eli Lilly’s treatment for type 2 diabetes

Posted on:May 13, 2022
7:14pm

– The U.S. Food & Drug Administration said on Friday it had approved Eli Lilly’s injection to help improve blood sugar control in adults with type 2 diabetes.

Company News, Diabetes, FDA, Health / Medicine, Healthcare (TRBC level 1), LILLY, Pharmaceuticals & Medical Research (TRBC level 2), Pharmaceuticals (NEC) (TRBC level 5), Pharmaceuticals (TRBC level 4), United States, US

Post navigation

Previous Post Previous post: Former Reagan national security adviser McFarlane dies -Washington Post
Next Post Next post: Texas high court says governor cannot order transgender child investigations

Similar Articles

Victoria sees COVID-19 cases rise as Australia endures lockdowns

Jul 21, 2021 | 11:41pm

Billie Eilish to headline Glastonbury music festival next year

Oct 04, 2021 | 10:31am

Greece’s neglected former Olympic venue to get major revamp by 2023

Jul 20, 2021 | 8:02pm

Latest

Health Life

Japan announces limited “test tourism” from May as step to full re-opening

May 17, 2022 | 4:03am

TOKYO – Japan said on Tuesday it would start conducting “test tourism” in the form of limited package tours in May as a way of gathering information prior to a full re-opening of the country to tourism. Though tourism was a major pillar of Japan’s economy, tourists have not been permitted to enter since it adopted strict border controls in 2020 at the start of the coronavirus pandemic. Regulations have been loosened slightly to allow…

Shanghai achieves ‘zero COVID’ status but normal life is weeks away

May 17, 2022 | 4:00am

Libya’s Bashagha arrives in Tripoli -Al Arabiya

May 17, 2022 | 3:43am

South Korea’s SK ties up with Bill Gates’ TerraPower for nuclear power opportunities

May 17, 2022 | 3:22am

China’s COVID controls will impact foreign investment for years – U.S. lobby

May 17, 2022 | 2:24am

Australia’s Brambles ends $14 billion takeover talks with CVC Capital

May 17, 2022 | 1:15am

Random

India to target children for COVID-19 vaccine from Oct -sources

Sep 22, 2021 | 5:58am

China’s AgBank posts 14% third-quarter profit increase

Oct 28, 2021 | 9:36am

CVS Health to hire 25,000 ahead of flu season, COVID-19 boosters

Sep 20, 2021 | 11:09am

Japan’s JERA to spend $1.58 billion to take 27% stake in Philippines’ Aboitiz Power

Sep 27, 2021 | 11:33am

Commentary: Don’t be fooled by Merkel’s aura of invincibility

Sep 19, 2017 | 6:33pm

Tags

Americas Asia / Pacific China (PRC) Company News Conflicts / War / Peace Content produced in Bangalore Coronavirus Corporate / Market Regulation Diplomacy / Foreign Policy Economic News (3rd Party) Emerging Market Countries Environment Epidemics Europe European Union Financials (Legacy) General News Germany Government / Politics HEALTH Health / Medicine Healthcare (TRBC level 1) Infectious Diseases International / National Security Japan Judicial Process / Court Cases / Court Decisions Major News Middle East Military Conflicts North America Picture available Pictures Public Health Reuters Top News Russia South America / Central America Sport United Kingdom United States US USA US Government News Vaccines Video Available Western Europe

About Us

We are the news and media division of the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information.

Contact Us

Phone US/CA: +1 (613) 416-8770
Email: support@cnwnews.ca
Copyright © 2022. All rights reserved.
  • Contact Us